Gargoyle Investment Advisor’s PDL BioPharma, Inc. PDLI Stock Holding History

Gargoyle Investment Advisor’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-64,473	Closed	-$324K	–	194
2015 Q3	$324K	Hold	64,473	–	–	0.13%	156
2015 Q2	$415K	Hold	64,473	–	–	0.16%	154
2015 Q1	$454K	Hold	64,473	–	–	0.17%	140
2014 Q4	$497K	Hold	64,473	–	–	0.18%	127
2014 Q3	$482K	Hold	64,473	–	–	0.18%	119
2014 Q2	$624K	Hold	64,473	–	–	0.23%	109
2014 Q1	$536K	Buy	64,473 +6,251	+11%	+$53.6K	0.24%	94
2013 Q4	$491K	Sell	58,222 -8,439	-13%	-$71.1K	0.23%	100
2013 Q3	$531K	Sell	66,661 -1,921	-3%	-$15.4K	0.33%	81
2013 Q2	$529K	Buy	+68,582	New	+$535K	0.27%	80

Other funds holding PDLI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Gargoyle Investment Advisor's PDLI Position: Q4 2015 in Review

Gargoyle Investment Advisor sold out of PDL BioPharma, Inc. (PDLI) in Q4 2015, closing a stake of 64,473 shares — an estimated $324K sold.

Gargoyle Investment Advisor first reported a position in PDLI in Q2 2013 and held it in 10 quarters. The position peaked at $624K in Q2 2014. 204 funds tracked by Wall St. Rank hold PDLI as of Q4 2015.

Gargoyle Investment Advisor reported no remaining PDL BioPharma, Inc. position as of Q4 2015 after selling out during the quarter.
Gargoyle Investment Advisor sold 64,473 PDL BioPharma, Inc. shares in Q4 2015, an estimated $324K.
Gargoyle Investment Advisor first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 10 quarters.
Gargoyle Investment Advisor's PDL BioPharma, Inc. position peaked at $624K in Q2 2014.
204 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2015.

Based on Gargoyle Investment Advisor's 13F filing for Q4 2015, filed 27 Jan 2016.